Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1974 1
1975 2
1978 1
1980 2
1981 2
1982 2
1983 3
1984 9
1985 10
1986 1
1987 4
1990 4
1991 1
1992 3
1993 5
1994 3
1995 1
1996 5
1997 3
1998 2
1999 3
2001 1
2002 1
2004 2
2005 4
2006 3
2007 1
2008 5
2009 4
2010 2
2012 2
2013 2
2014 1
2015 2
2016 1
2017 6
2018 6
2019 4
2020 1
2022 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.
Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat MC, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon JP. Aupérin A, et al. Among authors: clamon g. J Clin Oncol. 2010 May 1;28(13):2181-90. doi: 10.1200/JCO.2009.26.2543. Epub 2010 Mar 29. J Clin Oncol. 2010. PMID: 20351327 Review.
Beta blockade as adjunctive breast cancer therapy: A review.
Phadke S, Clamon G. Phadke S, et al. Among authors: clamon g. Crit Rev Oncol Hematol. 2019 Jun;138:173-177. doi: 10.1016/j.critrevonc.2019.04.006. Epub 2019 Apr 18. Crit Rev Oncol Hematol. 2019. PMID: 31092374 Review.
The clinical significance of soluble PD-1 and PD-L1 in lung cancer.
Abu Hejleh T, Furqan M, Ballas Z, Clamon G. Abu Hejleh T, et al. Among authors: clamon g. Crit Rev Oncol Hematol. 2019 Nov;143:148-152. doi: 10.1016/j.critrevonc.2019.08.009. Epub 2019 Sep 11. Crit Rev Oncol Hematol. 2019. PMID: 31675543 Review.
O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.
Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, Berg DJ, Zhang J, Keech J, Parekh KR, Bhatia S, Monga V, Bodeker KL, Ahmann L, Vollstedt S, Brown H, Shanahan Kauffman EP, Schall ME, Hohl RJ, Clamon GH, Greenlee JD, Howard MA, Schultz MK, Smith BJ, Riley DP, Domann FE, Cullen JJ, Buettner GR, Buatti JM, Spitz DR, Allen BG. Schoenfeld JD, et al. Among authors: clamon gh. Cancer Cell. 2017 Apr 10;31(4):487-500.e8. doi: 10.1016/j.ccell.2017.02.018. Epub 2017 Mar 30. Cancer Cell. 2017. PMID: 28366679 Free PMC article. Clinical Trial.
115 results